Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer
PHASE3
The purpose of this study is to compare the pathological complete response ...
A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer
PHASE3
The study is being conducted to assess the efficacy and safety of anthracyc...
Status
Unknown
Location
Breast Oncology, Tianjin Medical University Cancer Institute and Hospital
Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review
N/A
The goal of this systematic review is to assess the effectiveness of neoadj...